Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Subscribe to Newsletter

October 2022 Issue of The Medicine Maker

This issue, we warm up for our upcoming 2022 Innovation Awards with a look back at 2021’s Grand Winner and two runners up: a software system, a new form of smart connector, and new equipment for analytical science. Within its pages you’ll also find a cell and gene expert weighing the pros and cons of LLV and AAV viral vectors, and the new head of the Drugs for Neglected Diseases initiative explaining why we need to decolonize drug development. Further politically-minded commentary is on offer in an opinion piece arguing that pharma needs a disruptive “Elon Musk” figure to turn the field on its head.

Download Issue
Register here to download any issue of The Medicine Maker for FREE.
Login
Receive content, products, events as well as relevant industry updates from The Medicine Maker and its sponsors.
Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

Articles featured in this issue

Business & Regulation Business Practice

Working Together to Unlock Innovation

| Chris Lord | 10 min read

How the incumbent pharma industry can learn and benefit from disruptive entrepreneurs.

Manufacture Facilities

The Grand Challenge: Oligonucleotides Under the Microscope

| Maryam Mahdi | 5 min read

How can pharma companies ensure the future success of the oligonucleotide therapeutic market?

Manufacture Contract Manufacturing Services

De-Risking Your Sterile Manufacturing Program

| Sponsored by Alcami | 6 min read

Pharma sponsors are increasingly looking to CDMOs to help reduce risk and push projects forward.

Discovery & Development Formulation

You Shouldn’t Need a Spoonful of Sugar

| Amie Gehris | 3 min read

What difference can taste-masking make to the patient experience?

Discovery & Development Drug Discovery

Getting Smarter with Small Molecule Discovery: Lessons Learned With Tom Mander

| Tom Mander | 17 min read

Tom Mander, Chief Executive Officer of Domainex looks back on his career in small molecules and shares his hopes for the future.

Manufacture Packaging

Getting to Grips with the E&L Threshold

| Stephanie Sutton | 8 min read

The PQRI has released new recommendations on E&Ls in parenterals.

Business & Regulation Business Practice

Champions of Cell and Gene Therapy

| Angus Stewart | 7 min read

In our third C+G Champions installment, we ask industry leaders in the cell and gene field about accessibility for the many

Discovery & Development Analytical Science

The Cutting Edge of Biopharma Analytics

| Angus Stewart | 7 min read

How can new analytical tech help biopharma manufacturers?

Manufacture Technology and Equipment

It’s All About Connecting

| Stephanie Sutton | 6 min read

The CPC MicroCNX Series Connectors were a runner up in our 2021 Innovation Awards. Find out what inspired their development.

Manufacture Bioprocessing - Single Use Systems

Scoping Out the Future of Single Use – Together

| Sponsored by Cytiva | 6 min read

Cytiva is working to address increasing demand for flexibility and component interchangeability.

Business & Regulation Marketing

Let’s Get Closer

| Emma Banks | 4 min read

Post-COVID-19, pharma has a better opportunity than ever before to get closer to patients.

Business & Regulation Supply Chain

The Dual Sourcing Approach

| Sponsored by PCI

How robust is your strategy? Are you prepared for supply chain interruption?

Discovery & Development Clinical Trials

From Viral Video to Magic Medicine

| Angus Stewart | 2 min read

In 2014, the Ice Bucket Challenge raised millions; eight years on, we have an FDA-approved therapy

Discovery & Development Clinical Trials

Every Disease Has its Day

| Stephanie Sutton | 2 min read

Is now finally the time for Alzheimer’s drug development to shine?

Other issues of 2022